Estrella Immunopharma, Inc. (NASDAQ:ESLA – Get Free Report) was the target of a significant drop in short interest in July. Estrella Immunopharma Stock Down 4.4%Shares of ESLA traded down $0.03 during trading hours on Thursday, reaching $0.74. Get Estrella Immunopharma alerts:Estrella Immunopharma (NASDAQ:ESLA – Get Free Report) last issued its earnings results on Saturday, May 16th. Estrella Immunopharma Company Profile(Get Free Report)Estrella Immunopharma, Inc, a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. See AlsoReceive News & Ratings for Estrella Immunopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Estrella Immunopharma and related companies with MarketBeat.com's FREE daily email newsletter.